Classification | LVH | Concentric remodeling | Concentric hypertrophy | Eccentric hypertrophy | ||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
Total | ||||||||
 Control | 1.00 |  | 1.00 |  | 1.00 |  | 1.00 |  |
 HT | 2.81 (2.43–3.26) | <0.001* | 1.32 (1.09–1.59) | 0.004* | 4.41 (3.28–5.92) | <0.001* | 2.24 (1.90–2.64) | <0.001* |
 HT + DM | 3.94 (3.08–5.03) | <0.001* | 1.23 (0.86–1.75) | 0.248 | 7.20 (4.91–10.55) | <0.001* | 2.38 (1.80–3.16) | <0.001* |
 HT | 1.00 |  | 1.00 |  | 1.00 |  | 1.00 |  |
 HT + DM | 1.40 (1.12–1.75) | 0.003* | 1.01 (0.72–1.42) | 0.953 | 1.61 (1.22–2.12) | 0.001* | 1.07 (0.83–1.39) | 0.604 |
Men | ||||||||
 Control | 1.00 |  | 1.00 |  | 1.00 |  | 1.00 |  |
 HT | 2.93 (2.31–3.72) | <0.001* | 1.71 (1.27–2.29) | <0.001* | 4.66 (2.95–7.35) | <0.001* | 2.27 (1.72–2.98) | <0.001* |
 HT + DM | 4.34 (2.98–6.33) | <0.001* | 1.83 (1.09–3.05) | 0.022 | 6.67 (3.68–12.10) | <0.001* | 2.98 (1.90–4.65) | <0.001* |
 HT | 1.00 |  | 1.00 |  | 1.00 |  | 1.00 |  |
 HT + DM | 1.41 (0.81–2.17) | 0.153 | 1.07 (0.66–1.74) | 0.777 | 1.42 (0.92–2.19) | 0.116 | 1.25 (0.84–1.87) | 0.274 |
Women | ||||||||
 Control | 1.00 |  | 1.00 |  | 1.00 |  | 1.00 |  |
 HT | 2.74 (2.26–3.31) | <0.001* | 1.12 (0.87–1.43) | 0.383* | 4.11 (2.78–6.08) | <0.001* | 2.24 (1.82–2.75) | <0.001* |
 HT + DM | 3.68 (2.65–5.10) | <0.001* | 0.95 (0.58–1.55) | 0.836 | 7.21 (4.35–11.95) | <0.001* | 2.11 (1.46–3.03) | <0.001* |
 HT | 1.00 |  | 1.00 |  | 1.00 |  | 1.00 |  |
 HT + DM | 1.38 (1.02–1.87) | 0.035* | 0.96 (0.60–1.55) | 0.865 | 1.71 (1.18–2.45) | 0.004* | 0.98 (0.70–1.38) | 0.898 |